GB1461323A - Alpha-aminoacyl-3-halo-cephalosporins - Google Patents

Alpha-aminoacyl-3-halo-cephalosporins

Info

Publication number
GB1461323A
GB1461323A GB809774A GB809774A GB1461323A GB 1461323 A GB1461323 A GB 1461323A GB 809774 A GB809774 A GB 809774A GB 809774 A GB809774 A GB 809774A GB 1461323 A GB1461323 A GB 1461323A
Authority
GB
United Kingdom
Prior art keywords
group
mono
protecting
hydrogen
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB809774A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of GB1461323A publication Critical patent/GB1461323A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1461323 Silylated x-aminoacyl-3-halo-cephalosporins ELI LILLY & CO 22 Feb 1974 [23 Feb 1973] 8097/74 Heading C3P [Also in Division C2] Novel compounds of the Formula I wherein R is phenyl,mono- or dihydroxy phenyl, mono or dihalophenyl, mono or dimethylphenyl, mono- or dimethoxyphenyl, 2- or 3-thienyl or 2- furyl; R 1 is hydrogen, benzyl, p-methoxybenzyl, p-nitrobenzyl, diphenylmethyl, 2,2,2- trichloroethyl, trimethylsilyl or t-butyl; R 2 is hydrogen or an amino-protecting group; X is fluoro, chloro or bromo and pharmaceutically acceptable salts thereof when R 1 or R 2 is hydrogen, may be prepared by (i) halogenating and acylating in either order a compound of the Formula II wherein R 3 is a carboxylic acid protecting ester forming group optionally followed by removal of the carboxylic acid protecting ester forming group and or the amino-protecting group or (ii) fluorinating a 3-alkyl or aryl sulphonate of a compound II (R 1 #H) having a protected amino group, followed by acylation. In the above process (i) when halogenation is effected as the first step a protecting acyl group may be introduced on the 7-amino group prior to halogenation and thereafter removed.
GB809774A 1973-02-23 1974-02-22 Alpha-aminoacyl-3-halo-cephalosporins Expired GB1461323A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33538173A 1973-02-23 1973-02-23

Publications (1)

Publication Number Publication Date
GB1461323A true GB1461323A (en) 1977-01-13

Family

ID=23311540

Family Applications (1)

Application Number Title Priority Date Filing Date
GB809774A Expired GB1461323A (en) 1973-02-23 1974-02-22 Alpha-aminoacyl-3-halo-cephalosporins

Country Status (37)

Country Link
JP (4) JPS6139313B2 (en)
AR (1) AR199510A1 (en)
AT (1) AT333953B (en)
BE (1) BE811495A (en)
BR (1) BR7401384D0 (en)
CA (1) CA1016537A (en)
CH (1) CH593988A5 (en)
CS (1) CS187409B2 (en)
CY (1) CY1043A (en)
DD (1) DD110278A5 (en)
DE (1) DE2408698C2 (en)
DK (1) DK153157C (en)
EG (1) EG11104A (en)
ES (1) ES423531A1 (en)
FI (1) FI63035C (en)
FR (1) FR2218877B1 (en)
GB (1) GB1461323A (en)
GT (1) GT197432133A (en)
HK (1) HK20080A (en)
HU (1) HU166849B (en)
IE (1) IE39046B1 (en)
IL (1) IL44262A (en)
IN (1) IN139620B (en)
KE (1) KE3027A (en)
MW (1) MW674A1 (en)
MY (1) MY8100024A (en)
NL (1) NL179057C (en)
NO (2) NO148375C (en)
OA (1) OA04809A (en)
PH (1) PH9616A (en)
PL (1) PL88702B1 (en)
RO (1) RO64663A (en)
SE (1) SE411212B (en)
SU (1) SU676166A3 (en)
YU (1) YU36970B (en)
ZA (1) ZA741191B (en)
ZM (1) ZM3574A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101805357A (en) * 2010-04-28 2010-08-18 陶灵刚 Cefaclor compound and novel preparation method thereof
CN103588790A (en) * 2013-11-29 2014-02-19 中国科学院长春应用化学研究所 Preparation method of 7-amino-3-chloro-3-cephem-4-carboxylic acid-p-nitrobenzyl ester
CN106632400A (en) * 2016-12-16 2017-05-10 石家庄柏奇化工有限公司 Method for preparing 7-ACCA by removing 4-nitrobenzyl through catalytic hydrogenation of Pd-C

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342197B (en) * 1975-02-20 1978-03-28 Ciba Geigy Ag NEW PROCESS FOR PRODUCING 3-CEPHEM CONNECTIONS
CH619233A5 (en) * 1975-07-31 1980-09-15 Ciba Geigy Ag
CH622802A5 (en) * 1975-08-20 1981-04-30 Ciba Geigy Ag
IE45158B1 (en) * 1976-08-16 1982-06-30 Lilly Co Eli 3-chloro-cephem synthesis
DE3508258A1 (en) * 1985-03-08 1986-09-18 Bayer Ag, 5090 Leverkusen SS LACTAMANTIBIOTICS, METHOD FOR THE PRODUCTION AND THEIR USE AS AND IN MEDICINAL PRODUCTS
DE3509618A1 (en) * 1985-03-16 1986-09-18 Bayer Ag, 5090 Leverkusen SS LACTAM ANTIBIOTICS, METHOD FOR THE PRODUCTION AND THEIR USE AS A MEDICINAL PRODUCT
JPS6436445U (en) * 1987-08-28 1989-03-06
DE3803169A1 (en) 1988-02-03 1989-08-17 Bayer Ag SS LACTAM ANTIBIOTICS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS AND IN MEDICINAL PRODUCTS
ES2010075A6 (en) * 1989-01-10 1989-10-16 Antibioticos Sa Process for the preparation of 3-chloro-cefem compounds.
JP2539459Y2 (en) * 1991-12-18 1997-06-25 三重ホーロー株式会社 Assembled garbage incinerator
IT1255458B (en) * 1992-05-11 1995-11-02 Col Marco Da PROCEDURE FOR THE PREPARATION OF HALOGENATED BETA-LACTAMIC DERIVATIVES
ES2079327B1 (en) 1994-12-13 1996-08-01 Lilly Sa PHARMACEUTICAL FORMULATIONS OF CEFACLOR.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
DE2265798C2 (en) * 1971-06-24 1985-09-26 Fujisawa Pharmaceutical Co., Ltd., Osaka Process for the preparation of oxoazetidine derivatives
AR206201A1 (en) * 1972-06-29 1976-07-07 Ciba Geigy Ag PROCEDURE FOR OBTAINING ACID COMPOUNDS 7BETA-AMINO-3-CEFEM-3-01-4-CARBOXILICO0-SUBSTITUIDOS

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101805357A (en) * 2010-04-28 2010-08-18 陶灵刚 Cefaclor compound and novel preparation method thereof
CN101805357B (en) * 2010-04-28 2012-01-11 陶灵刚 Cefaclor compound and novel preparation method thereof
CN103588790A (en) * 2013-11-29 2014-02-19 中国科学院长春应用化学研究所 Preparation method of 7-amino-3-chloro-3-cephem-4-carboxylic acid-p-nitrobenzyl ester
CN106632400A (en) * 2016-12-16 2017-05-10 石家庄柏奇化工有限公司 Method for preparing 7-ACCA by removing 4-nitrobenzyl through catalytic hydrogenation of Pd-C

Also Published As

Publication number Publication date
HU166849B (en) 1975-06-28
NL7402489A (en) 1974-08-27
AU6591674A (en) 1975-08-28
SE411212B (en) 1979-12-10
MY8100024A (en) 1981-12-31
CH593988A5 (en) 1977-12-30
AR199510A1 (en) 1974-09-09
IL44262A (en) 1977-08-31
CY1043A (en) 1980-08-01
GT197432133A (en) 1975-08-16
JPS56138191A (en) 1981-10-28
SU676166A3 (en) 1979-07-25
IN139620B (en) 1976-07-10
MW674A1 (en) 1975-04-09
ES423531A1 (en) 1976-05-16
IE39046L (en) 1974-08-23
IL44262A0 (en) 1974-05-16
BE811495A (en) 1974-08-22
JPS49110689A (en) 1974-10-22
NO148375B (en) 1983-06-20
NL179057B (en) 1986-02-03
OA04809A (en) 1980-08-31
JPS6139313B2 (en) 1986-09-03
IE39046B1 (en) 1978-07-19
PH9616A (en) 1976-01-20
DE2408698A1 (en) 1974-09-05
YU36970B (en) 1984-08-31
KE3027A (en) 1980-03-14
FR2218877A1 (en) 1974-09-20
AT333953B (en) 1976-12-27
ATA142574A (en) 1976-04-15
NO740606L (en) 1974-08-26
RO64663A (en) 1979-02-15
PL88702B1 (en) 1976-09-30
YU39974A (en) 1982-06-18
NO148377B (en) 1983-06-20
NO148375C (en) 1983-09-28
ZM3574A1 (en) 1975-11-21
ZA741191B (en) 1975-10-29
JPS6140235B2 (en) 1986-09-08
DK153157B (en) 1988-06-20
JPS56138192A (en) 1981-10-28
DK153157C (en) 1988-10-31
FI63035B (en) 1982-12-31
HK20080A (en) 1980-04-25
NO792681L (en) 1974-08-26
FR2218877B1 (en) 1977-03-11
CS187409B2 (en) 1979-01-31
BR7401384D0 (en) 1974-11-05
JPS56138190A (en) 1981-10-28
FI63035C (en) 1983-04-11
DE2408698C2 (en) 1983-11-10
DD110278A5 (en) 1974-12-12
NL179057C (en) 1986-07-01
EG11104A (en) 1976-12-31
JPS6140236B2 (en) 1986-09-08
NO148377C (en) 1983-09-28
JPS6140237B2 (en) 1986-09-08
CA1016537A (en) 1977-08-30

Similar Documents

Publication Publication Date Title
GB1461323A (en) Alpha-aminoacyl-3-halo-cephalosporins
GB1526978A (en) 3-thiosubstituted cephalosporin antibiotics
LU88579I2 (en) ATOVAQUONE and its pharmaceutically acceptable salts (WELLVONE R)
ES452361A1 (en) Process for manufacture of 9-amino-9-deoxyclavulanates
GB1341712A (en) 3-formyl cephalosporin sulphoxides
IE34181L (en) Cephalosporins, intermediates for cephalexin
GB1454399A (en) Alphaaminoacyl cephalosporin ethers
SE7713901L (en) TIOOXIMCEPHALOSPORIN AND PENICILLIN DERIVATIVES
ES446907A1 (en) Crystalline form of sodium O-formylcefamandole
PL238200A1 (en) Process for preparing novel penicillins
GB1501711A (en) Hydroxy-substituted cephalosporins
GB1462944A (en) Process for preparing cephalosporins
GB1314628A (en) Method for preparing penicillin sulphoxides
GB1425571A (en) Penicillins and cephaosporins
GB1346744A (en) Betalactam compounds and process for preparing same
ES464008A1 (en) Monocyclic beta-lactams with antibacterial activity
GB1421280A (en) 3-heterocyclicthiomethylcephalosporins
GB1457668A (en) Cephalo
GB1261780A (en) Orally active sulfur-containing cephalosporin antibiotics
GB1507723A (en) Acyloxymethyl cephalosporin esters
GB1399349A (en) Process for acylation of dephalosporin esters
ES8106906A1 (en) Process for the preparation of penam derivatives.
JPS5671092A (en) Optical active cephalosporin analogous derivative
GB1413289A (en) Cephalosporin intermediates and a process for the preparation thereof
ES477209A1 (en) Preparation of the pivaloyloxymethyl ester of Cephalexin

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
49R Reference inserted (sect. 9/1949)
SP Amendment (slips) printed
704A Declaration that licence is not available as of right for an excepted use (par. 4a/1977)
PE20 Patent expired after termination of 20 years

Effective date: 19940221